Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Degardin

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Cancer. Part B, Oral Oncology|March 1, 1995
Phase II study of cystemustine in advanced head and neck cancer. A trial of the EORTC Clinical Screening GroupP Cappelaere, M A Lentz, M Degardin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Vinorelbine (navelbine) as a salvage treatment for advanced breast cancerM Degardin, J Bonneterre, B Hecquet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A phase II study of piritrexim in patients with advanced squamous cell carcinoma of the head and neckM Degardin, C Domenge, P Cappelaere, et al.
Investigational New Drugs|January 1, 1995
A clinical screening cooperative group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancerM Degardin, J P Armand, B Chevallier, et al.
Therapie|September 1, 1992
[Multicenter prospective study of cardiac accidents during treatments with 5-FU]F Sorbette, I Simon, J Bonneterre, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group studyF Duffaud, M Borner, P Chollet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 15, 2014
A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neckT Y Seiwert, J Fayette, D Cupissol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckM Degardin, J Oliveira, L Geoffrois, et al.
British Journal of Cancer|September 5, 2001
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neckX Pivot, E Raymond, B Laguerre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancyM Pecherstorfer, Z Herrmann, J J Body, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Cancer. Part B, Oral Oncology|March 1, 1995
Phase II study of cystemustine in advanced head and neck cancer. A trial of the EORTC Clinical Screening GroupP Cappelaere, M A Lentz, M Degardin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Vinorelbine (navelbine) as a salvage treatment for advanced breast cancerM Degardin, J Bonneterre, B Hecquet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A phase II study of piritrexim in patients with advanced squamous cell carcinoma of the head and neckM Degardin, C Domenge, P Cappelaere, et al.
Investigational New Drugs|January 1, 1995
A clinical screening cooperative group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancerM Degardin, J P Armand, B Chevallier, et al.
Therapie|September 1, 1992
[Multicenter prospective study of cardiac accidents during treatments with 5-FU]F Sorbette, I Simon, J Bonneterre, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group studyF Duffaud, M Borner, P Chollet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 15, 2014
A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neckT Y Seiwert, J Fayette, D Cupissol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckM Degardin, J Oliveira, L Geoffrois, et al.
British Journal of Cancer|September 5, 2001
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neckX Pivot, E Raymond, B Laguerre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancyM Pecherstorfer, Z Herrmann, J J Body, et al.
Pageof 3